Target intelligence / Profile preview

SCFA receptors

Molecular classification
G protein-coupled receptor, Receptor, Membrane protein
01

Overview

Free fatty acid receptor 2 (FFAR2, GPR43) and Free fatty acid receptor 3 (FFAR3, GPR41) are the primary G protein-coupled receptors for short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate. These receptors are expressed on the surface of multiple cell types—including immune cells, gut epithelial cells, and neurons—and play key roles in regulating host metabolism, energy homeostasis, hormone and neurotransmitter secretion, and immune responses. They serve as molecular mediators of gut microbiota-derived SCFA effects on both local intestinal and systemic physiology. Dysregulation or impaired signaling through these receptors has been linked to inflammatory diseases, cardiovascular disease, and neurodegenerative conditions. While termed 'SCFA receptors', this grouping encompasses several GPCRs; the most functionally and therapeutically relevant are FFAR2 and FFAR3.

Other names
FFAR2GPR43FFAR3GPR41SCFA receptorSCFARshort-chain fatty acid receptor
02

Mechanism of action

FFA2 and FFA3 are activated by binding SCFAs, leading to G protein-mediated intracellular signaling that impacts inflammation, metabolism, and hormone secretion. Activation of FFA2/FFA3 results in modulation of cyclic AMP, calcium signaling, and downstream cytokine release.

03

Biological functions

Signal transductionImmune responseHormone/neurotransmitter secretionEnergy metabolism regulationInflammatory response modulation
04

Disease associations

InflammationCardiovascular diseaseMetabolic disorders (e.g., obesity, diabetes)Neurodegenerative disease (e.g., Alzheimer's disease)
05

Safety considerations

Poor selectivity and specificity of current tool compounds limit clinical translationOff-target effects related to pleiotropic roles of SCFAs and broad tissue expressionPotential systemic metabolic and immune effects due to gut-wide receptor expression
06

Interacting drugs

4-methoxy-3-methyl-benzoic acid (MOMBA)
07

Biomarkers

Expression levels of FFAR2/FFAR3 in tissuesCirculating SCFA concentration

Beyond the preview

Go deeper on SCFA receptors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCFA receptors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call